Evidence mapPaperPMID 41858861Full record

ArticleFrontiers in endocrinology2026

Clinical characteristics of type 2 diabetes mellitus patients with erectile dysfunction.

Jiping Cao, Yang Zhang, Wei Jiang, Ying Fang, Yele Zhang, Lin Jiang

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiping Cao *Department of Nutrition, Jiangsu Provincial People's Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yang Zhang *Department of Radiology, Jiangsu Provincial People's Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wei Jiang *Department of Radiology, Jiangsu Provincial People's Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ying FangDepartment of Nutrition, Jiangsu Provincial People's Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yele ZhangDepartment of Radiology, Jiangsu Provincial People's Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Lin JiangDepartment of Nutrition, Jiangsu Provincial People's Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder and erectile dysfunction (ED) is a common complication among male patients with T2DM. Although T2DM is a well-established independent risk factor for ED the clinical characteristics and associated psychosocial burden of ED in this population remain inadequately characterized. This study aimed to comprehensively assess the prevalence, severity, clinical correlates, and emotional comorbidities of ED in male patients with T2DM. Objective: The incidence and related factors of T2DM patients with ED (T2DMED) were investigated by clinical symptom collection and related scale evaluation. The emotional abnormalities of T2DMED patients and their relationships with clinical features were evaluated by the Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMD). Methods: A total of 208 male patients with T2DM who presented to the Department of Endocrinology in Jiangsu Provincial People's Hospital from July 2020 to March 2021 were selected. The demographic information and T2DM related clinical data were collected. The scales of HAMA, HAMD, and sexual function questionnaires including International Erectile Function Index (IIEF-5), Premature Ejaculation Diagnostic Tool (PEDT) and Arizona Sexual Experience Scale (ASEX) were evaluated. Statistical analysis was conducted based on the patient's demographic information, clinical indicators, and scale data. Results: The prevalence of ED in male patients with T2DM was 67.8%. The prevalences of mild, moderate and severe ED were 57.2%, 5.3%, 5.3%, respectively. Compared with the group of T2DM, higher age, lower IIEF score, higher PEDT score, higher ASEX score, increased left and right pulse wave velocity (PWV) were detected in the T2DMED group. In addition, age and fasting insulin had positive impacts on the development of ED in T2DM patients. HbA1C, age and educational level had impacts on the severity of ED. The severity of ED was positively correlated with low-density lipoprotein (LDL) level, age, left ankle brachial index (ABI), left and right PWV. There were negative correlations between IIEF-5 scores and HAMA, HAMD scores in T2DM patients. PEDT scores were positively correlated with HAMA and HAMD scores while ASEX scores were positively correlated with HAMA scores. The HAMA scores were positively correlated with the duration of T2DM and HAMA scores had negative effects on IIEF scores. Conclusion: Mild ED is more common in T2DM patients with more serious sexual dysfunction and higher risk of diabetic vasculopathy. Higher age and fasting insulin level are associated with the development of T2DMED while HbA1C, age and education level affect the severity of ED, with higher levels of low-density lipoprotein (LDL) and age, high risk of diabetic vasculopathy indicating more severe ED. The sexual dysfunction was positively associated with both anxiety and depression, especially in patients with higher age.

Indexed as

Diabetes Mellitus, Type 2Erectile DysfunctionAdultAgedChinaHumansMaleMiddle AgedPrevalenceRisk Factorsanxietyclinical featuresdepressionerectile dysfunctiontype 2 diabetes mellitus

Identifiers

PMID41858861
PMCPMC12995602

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.